Translate
Revolution Medicines, Inc.
About
151.56USD-2.17 -1.41%
Closed • Updated at 12:57 GMT+00:00Market Cap$32.22B
Volume1.94M
Beta2.38
RSI61.33
Revolution Medicines, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 21 2026
Revolution Medicines to Host Investor Conference Call on Positive RASolute 302 Results Following 2026 ASCO Presentation
May 6 2026
Revolution Medicines Announces Publication in New England Journal of Medicine of Phase 1/2 Clinical Data on Daraxonrasib in Pancreatic Cancer
May 6 2026
Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress
Apr 29 2026
Revolution Medicines to Report Financial Results for First Quarter 2026 After Market Close on May 6, 2026
Apr 21 2026
Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting
Recent Videos
The largest synthetic royalty deal in biotech
May 23, 2026
Acquiring another company just for their cash?
May 22, 2026
RVMD ran an IPO right before market crashed
May 21, 2026
如何在生物技术寒冬中生存？RVMD的IPO时机
May 20, 2026
Community Chat
Ask AI
Try asking